Effect of rofecoxib on nociception and the serotonin system in the rat brain

Inflammation Research

Volumn 51, Issue 3, 2002, Pages 154-159

  Sandrini, M ^a   Vitale, G ^a   Pini, L A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

5 HT levels; 5 HT2 receptors; Antinociception; Rats; Rofecoxib

Indexed keywords

FENCLONINE; MU OPIATE RECEPTOR; ROFECOXIB; SEROTONIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOT PLATE TEST; LIGAND BINDING; MALE; NOCICEPTION; NONHUMAN; RAT; SEROTONINERGIC SYSTEM;

EID: 0036219340     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000287     Document Type: Article

References (42)

1. Prostaglandin endoperoxide H synthase1 and-2
2. Role of inducible cyclooxygenase-2 (COX-2) in inflammation
3. Effects of nonsteriodal anti-inflammatory drugs on platelets function and systemic homeostasis
4. Scientific rationale for specific inhibition of COX-2
5. Anti-inflammatory drugs and their mechanism of action
6. Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation
7. Biochemical and pharmacological profile of a tetrasubstituted furanone as a high selective COX-2 inhibitor
8. Rofecoxib [vioxx, MK-0966;4-(4-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles
9. Rofecoxib
10. A randomizated trial of efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis
11. Characterization of rofecoxib a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
12. Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain
13. The safety profile, tolerability, and effective dose-range of rofecoxib in the treatment of rheumatiod arthritis
14. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
15. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
16. Comparison of the effect of rofecoxib (a cyclooxygenase-2 inhibitor), ibuprofen, and placebo on the gastrointestinal mucosa of patients with osteoarthritis: A randomised, double-blind, placebo-controlled trial
17. Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid
18. Naloxone-reversible antinociception by paracetamol in the rat
19. Antagonism of the analgesic effect of opioid and non-opioid agents by p-chloro-phenylalanine (PCPA)
20. Full automation of serotonin determination by column switching and HPLC
21. 3H]ligand for serotonin binding sites
22. Opioid receptors and neuropeptides in CNS in rats treated chronically with amoxapine of amitriptyline
23. Rofecoxib. A review in its use in the management of ostheoarthritis, acute pain and rheumatoid arthritis
24. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs
25. A modified hot-plate test sensitive to mild analgesics
26. Afferent C fiber and A-delta activity in models of inflammation
27. The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain
28. Antinociceptive effect of paracetamol in rats is partially dependent on spinal serotonergic systems
29. Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain
30. Behavioural evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (±)-1-(2,5-dimetoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin
31. Effect of acetylsalicylic acid on serotonin brain receptor subtypes
32. Serotonin and nociception
33. Central antinociceptvce effects of nonsteroidal anti-inflammatory drugs and paracetamol
34. Peripheral and spinal mechanisms of nociception
35. Receptor mediation of 5-HT-induced inflammation and nociception in rats
36. Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat
37. 3 receptors
38. Ventromedial thalamic neurons convey nociceptive signals from the whole body to the dorsoventral neocortex
39. Pharmacological regulation of descending cortical control of the nociceptive processing
40. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
41. New insights on the mode of action of anti-inflammatory drugs